Drugs / iPSC-Exos
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05886205 | Jun 2023 → Jun 2025 | focal epilepsy | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iPSC-Exos | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05886205 ↗ |
| Known as | GD-iEXo-002 | “Exploratory Clinical Study on Induced Pluripotent Stem Cell Derived Exosomes (GD-iEXo-002) Nasal Drops for the Treatment of Refractory Focal Epilepsy” NCT05886205 ↗ |
| Route | Intranasal | “iPSC-Exos were administrated for nasal drip, bid for 12 weeks.” NCT05886205 ↗ |